BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17130620)

  • 1. Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.
    Milberger S; Davis RM; Douglas CE; Beasley JK; Burns D; Houston T; Shopland D
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv17-26. PubMed ID: 17130620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
    Douglas CE; Davis RM; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective.
    Cummings KM; Brown A; Douglas CE
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv84-9. PubMed ID: 17130628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scottish court dismisses a historic smoker's suit.
    Friedman L; Daynard R
    Tob Control; 2007 Oct; 16(5):e4. PubMed ID: 17897973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.
    Goldberg ME; Davis RM; O'Keefe AM
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv54-67. PubMed ID: 17130625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economics on trial: the use and abuse of economic methods in third party tobacco litigation.
    Max W; Tsoukalas T
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv77-83. PubMed ID: 17130627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
    Cummings KM; Morley CP; Hyland A
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.
    Davis RM; Douglas CE; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv4-8. PubMed ID: 17130623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential reduced exposure products (PREPs) in industry trial testimony.
    Wayne GF
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv90-7. PubMed ID: 17130630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testimony by otolaryngologists in defense of tobacco companies 2009-2014.
    Jackler RK
    Laryngoscope; 2015 Dec; 125(12):2722-9. PubMed ID: 26186270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The divergence between scientific and legal approaches concerning the cause of effects of tobacco use under Spanish law.
    Arcos Vieira ML
    Med Law; 2010 Jun; 29(2):171-82. PubMed ID: 22462282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cigarette controversy.
    Cummings KM; Brown A; O'Connor R
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1070-6. PubMed ID: 17548665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correcting over 50 years of tobacco industry misinformation.
    Smith P; Bansal-Travers M; O'Connor R; Brown A; Banthin C; Guardino-Colket S; Cummings KM
    Am J Prev Med; 2011 Jun; 40(6):690-8. PubMed ID: 21565663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proving Causation With Epidemiological Evidence in Tobacco Lawsuits.
    Lee SG
    J Prev Med Public Health; 2016 Mar; 49(2):80-96. PubMed ID: 27055545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the New York State cigarette fire safety standard on ignition propensity, smoke constituents, and the consumer market.
    Connolly GN; Alpert HR; Rees V; Carpenter C; Wayne GF; Vallone D; Koh H
    Tob Control; 2005 Oct; 14(5):321-7. PubMed ID: 16183983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Science and persuasion: environmental disease in U.S. courts.
    Boden LI; Miyares JR; Ozonoff D
    Soc Sci Med; 1988; 27(10):1019-29. PubMed ID: 3059501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of industry responsibility and tobacco control policy by US tobacco company executives in trial testimony.
    Chaiton M; Ferrence R; LeGresley E
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv98-106. PubMed ID: 17130631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll.
    Proctor RN
    Tob Control; 2012 Mar; 21(2):87-91. PubMed ID: 22345227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.